A prospective, multicenter cancer clinical trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) has validated an improved method for predicting treatment benefits in patients with hormone receptor-positive (HR+) metastatic breast…
A study of more than 45,000 women found that screening women according to their level of risk was as effective in detecting tumors as the one-size-fits-most screening currently recommended.
Davina McCall was moved to tears when a cancer patient at Addenbrooke's Hospital asked her how she was doing during the Cancer Clinic Live segment for Stand Up To Cancer 2025 on Friday.
(MedPage Today) -- SAN ANTONIO -- Risk-based breast cancer screening proved noninferior for detecting clinically significant tumors in a randomized trial, though outside experts raised concerns and a major medical group said the findings…
(MedPage Today) -- SAN ANTONIO -- Many patients with early breast cancer can safely skip sentinel lymph node biopsy (SLNB), results of a large Dutch study suggested.